The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
The cognitive benefits of modafinil to patients undergoing 7-day inpatient withdrawal from methamphetamine (MA) dependence were examined as part of a double-blind, randomized, placebo-controlled pilot trial. Recent evidence has identified modafinil-related improvements in treatment outcomes for MA-dependent patients; however, the benefits to cognition function, which is critical to treatment success but known to be impaired, has yet to be examined. The first 20 participants recruited to the study were administered either 200 mg of modafinil (once daily) or placebo, and a neuropsychological test battery (including an MA version of the emotional Stroop task) at admission (n = 17) and discharge (n = 14). Follow-up interviews were conducted at 1-month postdischarge (n = 13). After participant withdrawals (3 in each group), treatment was associated with a significant improvement in immediate verbal memory recall and nonsignificant trend toward improvement on executive function and delayed memory tasks. No benefit was seen for measures of verbal learning, visual memory, processing speed, or verbal fluency. All participants showed a significant attentional bias for MA-related stimuli on the emotional Stroop task. The magnitude of bias predicted both retention in treatment and relapse potential at follow-up but was not significantly ameliorated by modafinil treatment. While nonsignificant, the effect sizes of modafinil-related improvements in executive function and memory were consistent with those found in more robustly powered studies of cognitive benefits in attention-deficit/hyperactivity disorder and schizophrenia, supporting the need for further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seven days of modafinil (200 mg/d) increased measures of verbal recall (65).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“nonsignificant -but improved- executive function and delayed memory tasks compared to placebo.”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as Hester, R. et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“Significantly improved verbal recall”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as Hester, R. et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Attentional bias in addictive behaviors: A review of its development, causes, and consequences
FIELD, M., & COX, W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.030 · Cited by 1,376
The Journal of Neuropsychiatry and Clinical Neurosciences
Bowden, V. M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110111047 · Cited by 1,223
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760 · cited 2×
“MA-related cognitive deficits have also been linked to a variety of cortical differences between MA users and matched controls, including fronto-cortical dysfunction (London et al., 2005; Monterosso et al., 2007; Paulus, Tapert, & Schuckit, 2005; Thompson, 2004), dopaminergic transporter levels (Mccann et al.”
BackgroundLoss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671 · cited 1×
“The neuropsychological performance of the current sample is also consistent with previous evidence of cognitive deficits observed in active and abstinent MA users (for reviews, see Meredith, Jaffe, & Ang-Lee, 2005; Nordahl, Salo, & Leamon, 2003; Scott et al., 2007), particularly in the domains of memory and learning (…”
ResultField, M., Munafò, M. R., & Franken, I. H. A. (2009) · Psychological Bulletin · doi:10.1037/a0015843 · Cited by 602
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529 · cited 1×
“, 2006), and resulting in increased extracellular dopamine in cortical regions critical to cognition (Volkow et al., 2009).”
BackgroundCognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 515 · cited 1×
“In healthy adults, modafinil has been associated with significant improvements in working memory and executive function (Turner et al., 2003), while sleep-deprived participants have shown more general benefits to attention, psychomotor speed, memory, and executive function (Gill, Haerich, Westcott, Godenick, & Tucker,…”
BackgroundThe nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458
Deficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 393
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374 · cited 1×
“, 2001), and striatal dopamine receptor levels (Lee et al., 2009).”
BackgroundClinical effectiveness of attentional bias modification training in abstinent alcoholic patients
Schoenmakers, T. M., de Bruin, M., Lux, I. F. M., Goertz, A. G., Van Kerkhof, D. H. A. T., & Wiers, R. W. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.022 · Cited by 373 · cited 1×
“Recent work has also demonstrated that psychological intervention with alcohol users (Schoenmakers et al., 2010) and pharmacological intervention with stimulant users (Ersche et al.”
BackgroundNORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Paulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.761 · Cited by 369
Alcohol attentional bias as a predictor of alcohol abusers’ treatment outcome
Cox, W. M., Hogan, L. M., Kristian, M. R., & Race, J. H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00219-3 · Cited by 340
Monterosso, J. R., Ainslie, G., Xu, J., Cordova, X., Domier, C. P., & London, E. D. (2007) · Human Brain Mapping · doi:10.1002/hbm.20281 · Cited by 335 · cited 1×
“MA-related cognitive deficits have also been linked to a variety of cortical differences between MA users and matched controls, including fronto-cortical dysfunction (London et al., 2005; Monterosso et al., 2007; Paulus, Tapert, & Schuckit, 2005; Thompson, 2004), dopaminergic transporter levels (Mccann et al.”
BackgroundAttentional bias predicts outcome in smoking cessation.
Waters, A. J., Shiffman, S., Sayette, M. A., Paty, J. A., Gwaltney, C. J., & Balabanis, M. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.4.378 · Cited by 332 · cited 1×
“2006), nicotine (Waters et al., 2003) and alcohol (Cox et al.”
BackgroundMadras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T. J., Bonab, A. A., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106583 · Cited by 326 · cited 1×
“The cognitive enhancing effects of modafinil have been associated with its action on the binding (or blocking) of dopamine and norepinephrine transporters (Hermant, Rambert, & Duteil, 1991; Madras et al., 2006), and resulting in increased extracellular dopamine in cortical regions critical to cognition (Volkow et al.”
BackgroundTurner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301
Kalechstein, A. D., Newton, T. F., & Green, M. M. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.2.215 · Cited by 288
Attentional bias predicts heroin relapse following treatment
Marissen, M. A. E., Franken, I. H. A., Waters, A. J., Blanken, P., Van Den Brink, W., & Hendriks, V. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01498.x · Cited by 280
Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia
Turner, D. C., Clark, L., Pomarol-Clotet, E., McKenna, P., Robbins, T. W., & Sahakian, B. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300457 · Cited by 258
Modafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235 · cited 1×
“Modafinil is a nonamphetamine psychostimulant that was initially approved for the treatment of narcolepsy but was subsequently shown to have success in clinical trials treating cocaine dependence (Anderson et al., 2009; Dackis, Kampman, Lynch, Pettinati, & O’Brien, 2005; Dackis et al., 2003).”
BackgroundCognitive Performance of Current Methamphetamine and Cocaine Abusers
Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_06 · Cited by 228 · cited 1×
“Chronic MA users tested during a nonintoxicated state consistently display cognitive deficits in memory, attention and psychomotor speed, as well as marked deficits on clinical neuropsychological and experimental measures of executive control (Salo, Nordahl, Moore, et al., 2002; Simon et al., 2002).”
BackgroundHester, R., Dixon, V., & Garavan, H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.07.002 · Cited by 217
Self-citationPersistent cognitive and dopamine transporter deficits in abstinent methamphetamine users
McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2008) · Synapse · doi:10.1002/syn.20471 · Cited by 206
Eye movements to smoking-related cues: effects of nicotine deprivation
Field, M., Mogg, K., & Bradley, B. P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1689-2 · Cited by 199
Performance on the Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals
Streeter, C. C., Terhune, D. B., Whitfield, T. H., Gruber, S., Sarid-Segal, O., Silveri, M. M., Tzilos, G., Afshar, M., Rouse, E. D., Tian, H., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301465 · Cited by 192 · cited 1×
“Given the relationship between cognitive control, attentional bias and abstinence in stimulant users (Carpenter et al., 2005; Copersino et al., 2004; Streeter et al., 2008), evidence for the efficacy of such medications in improving cognition would be of great value.”
BackgroundCarpenter, K. M., Schreiber, E., Church, S., & McDowell, D. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.04.012 · Cited by 189 · cited 1×
“Given the relationship between cognitive control, attentional bias and abstinence in stimulant users (Carpenter et al., 2005; Copersino et al., 2004; Streeter et al., 2008), evidence for the efficacy of such medications in improving cognition would be of great value.”
BackgroundPreliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals
Salo, R., Nordahl, T. E., Possin, K., Leamon, M., Gibson, D. R., Galloway, G. P., Flynn, N. M., Henik, A., Pfefferbaum, A., & Sullivan, E. V. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00111-7 · Cited by 188
Bradley, B., Field, M., Mogg, K., & De Houwer, J. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200402000-00004 · Cited by 187
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J. W., Rowan, A., Poole, S., White, L., & O'Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186 · cited 1×
“Modafinil is a nonamphetamine psychostimulant that was initially approved for the treatment of narcolepsy but was subsequently shown to have success in clinical trials treating cocaine dependence (Anderson et al., 2009; Dackis, Kampman, Lynch, Pettinati, & O’Brien, 2005; Dackis et al., 2003).”
BackgroundNeurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence
Franken, I. H. A., Stam, C. J., Hendriks, V. M., & van den Brink, W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1542-7 · Cited by 161
Greenhill, L. L., Biederman, J., Boellner, S. W., Rugino, T. A., Sangal, R. B., Earl, C. Q., JIANG, J. G., & Swanson, J. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000205709.63571.c9 · Cited by 160
A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure
González, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., Cherner, M., & Grant, I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.04.014 · Cited by 146 · cited 1×
“, 2007), particularly in the domains of memory and learning (Gonzalez, 2004; Kalechstein, Newton, & Green, 2003), psychomotor speed (Volkow, Chang, Wang, Fowler, et al.”
BackgroundThe relationship between crystalline methamphetamine use and methamphetamine dependence
McKetin, R., Kelly, E., & McLaren, J. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.007 · Cited by 145
The effect of relapse on cognition in abstinent methamphetamine abusers
Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.03.011 · Cited by 142 · cited 3×
“, 2010); however, over shorter periods of abstinence neuropsychological performance has been shown to decline further (Mccann et al., 2007; Simon et al., 2004; Simon et al., 2010).”
BackgroundMethodCerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers
London, E. D., Berman, S. M., Voytek, B., Simon, S. L., Mandelkern, M. A., Monterosso, J., Thompson, P. M., Brody, A. L., Geaga, J. A., Hong, M. S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.039 · Cited by 136 · cited 1×
“MA-related cognitive deficits have also been linked to a variety of cortical differences between MA users and matched controls, including fronto-cortical dysfunction (London et al., 2005; Monterosso et al., 2007; Paulus, Tapert, & Schuckit, 2005; Thompson, 2004), dopaminergic transporter levels (Mccann et al.”
BackgroundTreatment for amphetamine withdrawal
Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003021.pub2 · Cited by 120
Franken, I. H. A., Kroon, L. Y., & Hendriks, V. M. (2000) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00112-9 · Cited by 117
Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117
Iudicello, J. E., Woods, S. P., Vigil, O., Cobb Scott, J., Cherner, M., Heaton, R. K., Hampton Atkinson, J., Grant, I., & Ce, T. H. N. R. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903512637 · Cited by 111 · cited 1×
“With prolonged abstinence (of at least 12 months), there is some recovery of function (Iudicello et al., 2010); however, over shorter periods of abstinence neuropsychological performance has been shown to decline further (Mccann et al.”
BackgroundErsche, K. D., Bullmore, E. T., Craig, K. J., Shabbir, S. S., Abbott, S., Müller, U., Ooi, C., Suckling, J., Barnes, A., Sahakian, B. J., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.60 · Cited by 108
Heinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.023 · Cited by 105 · cited 2×
“While larger studies of modafinil treatment for MA dependence have been conducted (De La Garza et al., 2010; Heinzerling et al., 2010; McElhiney et al., 2009; McGregor et al., 2008; Shearer et al., 2009), none have to date examined the influence on cognitive function.”
BackgroundImpact of Modafinil on Prefrontal Executive Function in Schizophrenia
Hunter, M. D., Ganesan, V., Wilkinson, I. D., & Spence, S. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2184 · Cited by 103
Hermant, J.-F., Rambert, F. A., & Duteil, J. (1991) · Psychopharmacology · doi:10.1007/bf02244069 · Cited by 99
Gill, M., Haerich, P., Westcott, K., Godenick, K. L., & Tucker, J. A. (2006) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2006.tb01665.x · Cited by 96
Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients
Copersino, M. L., Serper, M. R., Vadhan, N. P., Goldberg, B. R., Richarme, D., Chou, J. C.-Y., Stitzer, M. L., & Cancro, R. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.07.006 · Cited by 94 · cited 1×
“Given the relationship between cognitive control, attentional bias and abstinence in stimulant users (Carpenter et al., 2005; Copersino et al., 2004; Streeter et al., 2008), evidence for the efficacy of such medications in improving cognition would be of great value.”
BackgroundKahbazi, M., Ghoreishi, A., Rahiminejad, F., Mohammadi, M.-R., Kamalipour, A., & Akhondzadeh, S. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.024 · Cited by 91 · cited 1×
“More recently, modafinil has been used to treat cognitive dysfunction in conditions such as attention-deficit/hyperactivity disorder (ADHD; Greenhill et al., 2006; Kahbazi et al., 2009), schizophrenia (Hunter, Ganesan, Wilkinson, & Spence, 2006; Morein-Zamir, Turner, & Sahakian, 2007; Turner, Clark, Pomarol-Clotet, et…”
MethodRandall, D. C., Fleck, N. L., Shneerson, J. M., & File, S. E. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.016 · Cited by 91
McGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., & White, J. M. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.003 · Cited by 82 · cited 3×
“While larger studies of modafinil treatment for MA dependence have been conducted (De La Garza et al., 2010; Heinzerling et al., 2010; McElhiney et al., 2009; McGregor et al., 2008; Shearer et al., 2009), none have to date examined the influence on cognitive function.”
BackgroundCox, W. M., Brown, M. A., & Rowlands, L. J. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg010 · Cited by 82
McLaughlin, D. F., McKenna, H., & Leslie, J. C. (2000) · Journal of Psychiatric and Mental Health Nursing · doi:10.1046/j.1365-2850.2000.00329.x · Cited by 76
Cherner, M., Suarez, P., Casey, C., Deiss, R., Letendre, S., Marcotte, T., Vaida, F., Atkinson, J. H., Grant, I., & Heaton, R. K. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.010 · Cited by 76 · cited 1×
“, 2001), and executive function (Cherner et al., 2010; Monterosso, Aron, Cordova, Xu, & London, 2005; Salo, Nordahl, Possin, Leamon, M., & Gibson, 2002; Salo et al., 2005; Simon et al., 2004; Simon, Dean, Cordova, Monterosso, & London, 2010).”
Garza, R. D. L., Zorick, T. S., London, E. D., & Newton, T. F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.013 · Cited by 64
McElhiney, M. C., Rabkin, J. G., Rabkin, R., & Nunes, E. V. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802342907 · Cited by 61 · cited 2×
“While larger studies of modafinil treatment for MA dependence have been conducted (De La Garza et al., 2010; Heinzerling et al., 2010; McElhiney et al., 2009; McGregor et al., 2008; Shearer et al., 2009), none have to date examined the influence on cognitive function.”
BackgroundA Review of the Effects of Modafinil on Cognition in Schizophrenia
Morein-Zamir, S., Turner, D. C., & Sahakian, B. J. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm090 · Cited by 55
A dissociation in attentional control: Evidence from methamphetamine dependence
Salo, R. E., NORDAHL, T. E., Moore, C. D., Waters, C., Natsuaki, Y., Galloway, G. P., Kile, S. J., & Sullivan, E. V. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.035 · Cited by 51 · cited 1×
“, 2001), and executive function (Cherner et al., 2010; Monterosso, Aron, Cordova, Xu, & London, 2005; Salo, Nordahl, Possin, Leamon, M., & Gibson, 2002; Salo et al., 2005; Simon et al., 2004; Simon, Dean, Cordova, Monterosso, & London, 2010).”
Levounis, P., Galanter, M., Dermatis, H., Hamowy, A., & Leon, G. D. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n03_05 · Cited by 42
Open-Label Pilot Study of Modafinil for Methamphetamine Dependence
McGaugh, J., Mancino, M. J., Feldman, Z., Chopra, M. P., Gentry, W. B., Cargile, C., & Oliveto, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b591e0 · Cited by 31 · cited 1×
“Recent randomized trials of modafinil to treat MA-dependent users (De La Garza et al., 2010; Heinzerling et al., 2010; McElhiney et al., 2009; McGaugh et al., 2009; McGregor et al., 2008; Shearer et al., 2009) have shown the drug to be well tolerated with limited side effects and minimal adverse events (particularly a…”
BackgroundModafinil, Sleep Deprivation, and Cognitive Function in Military and Medical Settings
Westcott, K. (2005) · Military Medicine · doi:10.7205/milmed.170.4.333 · Cited by 29 · cited 2×
“Westcott, K. J. (2005). Modafinil, sleep deprivation, and cognitive function in military and medical settings.”
Background
Cited by
Cognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 298
“inpatient study, 7 days of modafinil treatment improved immediate verbal memory function (Hester et al., 2010).”
BackgroundMereu, M., Bonci, A., Newman, A. H., & Tanda, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3232-4 · Cited by 148
“…subjects, none of them found statistically significant improvements in urine detection of metabolites, abstinence, depressive symptoms, or craving (Anderson et al. 2012; De La Garza et al. 2010; Heinzerling et al. 2010; Hester et al. 2010; Lee et al. 2013; McGaugh et al. 2009; Shearer et al. 2009).”
Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis
Cumming, C., Troeung, L., Young, J. T., Kelty, E., & Preen, D. B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.001 · Cited by 131
Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches
Cadet, J. L., & Bisagno, V. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00189 · Cited by 129
“org METH use increase the risk of poorer health outcomes, high-risk behaviors, treatment non-adherence, and repeated relapses (110, 118).”
BackgroundCognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2016) · Journal of Dual Diagnosis · doi:10.1080/15504263.2016.1146383 · Cited by 109
“Findings suggest a strong attentional bias to cocaine (see Leeman, Robinson, Waters, & Sofuoglu, 2014 for a review) and methamphetamine cues (Hester et al., 2010).”
Background
Metadata
- Authors
- Hester, R., Lee, N., Pennay, A., Nielsen, S., & Ferris, J.
- Affiliations
- The University of Melbourne (AU)
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2010-12
- Volume
- 18
- Issue
- 6
- Pages
- 489-497
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W2134746607
- Cited by
- 42
- References
- 68
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 1 · 2014: 2 · 2013: 6 · 2012: 3
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Government Department of Health and Ageing
- National Health and Medical Research Council (519730)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- modafinil, methamphetamine dependence, attentional bias, emotional Stroop task, neuropsychological performance, verbal memory, executive function, treatment retention, relapse, cognitive impairment
- MeSH terms
- Modafinil, Adult, Central Nervous System Stimulants, Attention, Benzhydryl Compounds, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Memory, Methamphetamine, Middle Aged, Neuropsychological Tests, Pilot Projects, Recurrence, Substance Withdrawal Syndrome, Treatment Outcome, Amphetamine-Related Disorders, Young Adult, Executive Function, Stroop Test
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.